Pfizer stock climbs on Q4 revenue and earnings beat, reaffirmed guidance

• Pfizer tops earnings estimates as Covid product sales beat expectations and cost cuts pay off

  The results cap off a critical year for Pfizer, which has been slashing costs as it recovers from the rapid decline of its Covid business and stock price.
  
  CNBC - 1h

• PayPal posts an earnings beat, but another metric is weighing on its stock

  PayPal’s stock is down 6%, with an analyst noting that growth in branded-checkout volume seems to have trailed buy-side expectations.
  
  MarketWatch - 4h

• Tyson Foods’ chicken business powers earnings beat as stock rises

  Tyson called the chicken results “exceptional.”
  
  MarketWatch - 1d

• Tractor Supply’s stock slides on narrow Q4 earnings miss, weaker-than-expected guidance

  Tractor Supply’s CEO said the company “performed well in a challenging retail environment.”
  
  MarketWatch - 5d

• T-Mobile’s stock climbs after fourth-quarter earnings beat and robust guidance

  T-Mobile expects postpaid net customer additions of between 5.5 million and 6 million for 2025, the company’s highest-ever guidance range issued at the beginning of the year.
  
  MarketWatch - 6d

• GM stock falls even as company beats analyst expectations on earnings

  While investors will be watching GM's quarterly results, they will also be focused on its guidance for 2025 and any changes under the Trump administration.
  
  CNBC - 6d

• SoFi’s stock sinks as a downbeat outlook negates a big revenue beat

  SoFi’s stock sinks as a mixed outlook overshadowed strong Q4 results that included the biggest revenue beat in about three years.
  
  MarketWatch - Jan. 27

• Wells Fargo shares jump after earnings beat, strong 2025 guidance

  The lender expects 2025 net interest income, a key measure of what a bank makes on lending, to be 1% to 3% higher than 2024's number of $47.7 billion.
  
  CNBC - Jan. 15
• 

  Experian Posts Revenue Growth in Line With Guidance

  The company reported total revenue growth of 8% at constant exchange rates for the third quarter of fiscal 2025, and confirmed its guidance for the year.
  
  The Wall Street Journal - Jan. 15

More from MarketWatch

• Trump has two strong options to defuse the U.S. debt time-bomb. He should use them.

  AI-fueled productivity growth, combined with realistic and constructive immigration reform, would put the U.S. economy on more solid footing.
  
  MarketWatch - 18m

• The end of insurance: Climate change is destroying homeowners and insurers

  Traditional insurance models aren’t able to handle escalating natural disaster risks.
  
  MarketWatch - 22m

• Trump, tariffs and your 401(k) — why it’s time to diversify

  Putting all your eggs in one basket is an especially bad idea now.
  
  MarketWatch - 58m

• People who make under $130,000 were already cutting back. Trump’s trade war will tighten the squeeze.

  Middle-income households are feeling financially stressed and negative about their financial outlook, and many are cutting spending for 2025.
  
  MarketWatch - 1h

• Job openings fall close to 4-year low. Finding work gets harder.

  It’s gotten harder for the unemployed to find work. Job openings in the U.S. fell at the end of 2024 to the second-lowest level since the end of the pandemic
  
  MarketWatch - 1h

More in Business

• Ferrari shares pop 8% as luxury carmaker sees further earnings growth in 2025

  Luxury carmaker Ferrari on Tuesday reported a significant upswing in full-year net profit, citing a strong product mix and growing demand for personalization.
  
  CNBC - 8m
• 

  Grammy Awards Audience Drops 9%

  The awards show drew 15.4 million people this year, down from nearly 17 million last year.
  
  The New York Times - 16m

• Trump has two strong options to defuse the U.S. debt time-bomb. He should use them.

  AI-fueled productivity growth, combined with realistic and constructive immigration reform, would put the U.S. economy on more solid footing.
  
  MarketWatch - 18m
• 

  New York Law Seeks to Protect Abortion-by-Mail Providers

  The new law in New York expands the state’s shield laws for healthcare providers.
  
  Inc. - 19m
• 

  As Trump’s Trade War Unfolds, American Companies Brace for Pain

  American companies intent on making goods in the United States are fretting over the impact of tariffs on their access to parts and raw materials.
  
  The New York Times - 20m